These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1535031)

  • 1. Rate of recovery of D1 and D2 dopaminergic receptors in young vs. adult rat striatal tissue following alkylation with ethoxycarbonyl-ethoxy-dihydroquinoline (EEDQ).
    Kula NS; George T; Baldessarini RJ
    Brain Res Dev Brain Res; 1992 Apr; 66(2):286-9. PubMed ID: 1535031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aging on striatal dopamine receptor subtype recovery following N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline blockade and relation to motor function in Wistar rats.
    Henry JM; Joseph JA; Kochman K; Roth GS
    Brain Res; 1987 Aug; 418(2):334-42. PubMed ID: 2960421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the rat.
    Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
    Neuropharmacology; 1994 May; 33(5):647-55. PubMed ID: 7936100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-dependent differences in the rate of recovery of striatal dopamine D1 and D2 receptors after inactivation with EEDQ.
    Crawford CA; Rowlett JK; McDougall SA; Bardo MT
    Eur J Pharmacol; 1994 Feb; 252(2):225-31. PubMed ID: 8157063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional recovery of D1 dopamine receptor-mediated stimulation of rat striatal adenylate cyclase activity following irreversible receptor modification by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): evidence for spare receptors.
    Battaglia G; Norman AB; Hess EJ; Creese I
    Neurosci Lett; 1986 Sep; 69(3):290-5. PubMed ID: 2945128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats.
    Lévesque D; Di Paolo T
    Mol Pharmacol; 1991 May; 39(5):659-65. PubMed ID: 1674586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics.
    Meller E; Bohmaker K; Goldstein M; Friedhoff AJ
    J Pharmacol Exp Ther; 1985 Jun; 233(3):656-62. PubMed ID: 2861276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of dopamine binding sites and changes in dopamine and dihydroxyphenylacetic acid levels in 17- and 90-day-old rat striatum after irreversible receptor antagonism.
    Crawford CA; McDougall SA; Rowlett JK; Bardo MT
    Neurosci Lett; 1992 Mar; 137(2):265-9. PubMed ID: 1350079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
    Morissette M; Lévesque D; Di Paolo T
    Mol Pharmacol; 1992 Sep; 42(3):480-8. PubMed ID: 1357544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo partial inactivation of dopamine D1 receptors induces hypersensitivity of cortical dopamine-sensitive adenylate cyclase: permissive role of alpha 1-adrenergic receptors.
    Trovero F; Hervé D; Blanc G; Glowinski J; Tassin JP
    J Neurochem; 1992 Jul; 59(1):331-7. PubMed ID: 1351927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aging on recovery of striatal dopamine receptors following N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) blockade.
    Henry JM; Roth GS
    Life Sci; 1984 Aug; 35(8):899-904. PubMed ID: 6482680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro.
    Hess EJ; Battaglia G; Norman AB; Creese I
    Mol Pharmacol; 1987 Jan; 31(1):50-7. PubMed ID: 3100940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on [3H]SCH23390 and [3H]forskolin binding in rat striatum.
    Norman AB; Wachendorf TJ; Sanberg PR
    Life Sci; 1989; 44(13):831-6. PubMed ID: 2648096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkylation of striatal dopamine receptors abolishes stereotyped behavior but has no effect on dopamine stimulated adenylate cyclase activity.
    Cameron DL; Crocker AD
    Neurosci Lett; 1988 Jul; 90(1-2):165-71. PubMed ID: 3045699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of substantia nigra dopamine cell firing by R(-)-N-n-propylnorapomorphine: electrophysiological and autoradiographic studies after regional inactivation of dopamine receptors by microinjection of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Cox RF; Waszczak BL
    Brain Res; 1993 Jun; 613(1):32-42. PubMed ID: 8102308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilateral inactivation of dopamine receptors after intrastriatal injection of N-ethoxy-carbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): a novel rotational model to investigate dopamine receptor interactions.
    Giorgi O; Biggio G
    Pharmacol Biochem Behav; 1990 Apr; 35(4):877-84. PubMed ID: 1971721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lesions of mouse striatum induced by 6-hydroxydopamine differentially alter the density, rate of synthesis, and level of gene expression of D1 and D2 dopamine receptors.
    Qin ZH; Chen JF; Weiss B
    J Neurochem; 1994 Feb; 62(2):411-20. PubMed ID: 8294904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
    Burger LY; Martin-Iverson MT
    Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential recovery rates of rat D2 dopamine receptors as a function of aging and chronic reserpine treatment following irreversible modification: a key to receptor regulatory mechanisms.
    Norman AB; Battaglia G; Creese I
    J Neurosci; 1987 May; 7(5):1484-91. PubMed ID: 2952771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.